Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001193125-26-457093

Chief Executive Officer bought 47,000 shares at $0.81 ($37,943)

From the SEC's structured data for this filing

Trades in this filing

Spoor Johan M. · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-11 Purchase : show line 1 in the form +47,000 $0.81 $37,943 106,383 D
Open-market purchases · 47,000 sh · avg $0.81 · $37,943
Loading xslF345X06/ownership.xml…